These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 8324746

  • 1. Self-reactive antibody expression by human carcinoma cells engineered with monoclonal antibody genes.
    Primus FJ, Finch MD, Masci AM, Schlom J, Kashmiri SV.
    Cancer Res; 1993 Jul 15; 53(14):3355-61. PubMed ID: 8324746
    [Abstract] [Full Text] [Related]

  • 2. Chimeric murine-human antibodies directed against folate binding receptor are efficient mediators of ovarian carcinoma cell killing.
    Coney LR, Mezzanzanica D, Sanborn D, Casalini P, Colnaghi MI, Zurawski VR.
    Cancer Res; 1994 May 01; 54(9):2448-55. PubMed ID: 7512887
    [Abstract] [Full Text] [Related]

  • 3. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
    Alvarez-Rueda N, Leprieur S, Clémenceau B, Supiot S, Sébille-Rivain V, Faivre-Chauvet A, Davodeau F, Paris F, Barbet J, Aubry J, Birklé S.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
    [Abstract] [Full Text] [Related]

  • 4. Enhanced cytotoxicity against colon carcinoma by combinations of noncompeting monoclonal antibodies to the 17-1A antigen.
    Fogler WE, Klinger MR, Abraham KG, Gottlinger HG, Riethmuller G, Daddona PE.
    Cancer Res; 1988 Nov 15; 48(22):6303-8. PubMed ID: 2460221
    [Abstract] [Full Text] [Related]

  • 5. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
    Liao SK, Horton L, Flahart RE, O'Rear L, Crumpacker D, Imbaratto JW, Yannelli JR, Robinson RR, Oldham RK.
    Hum Antibodies Hybridomas; 1990 Nov 15; 1(2):66-76. PubMed ID: 2103354
    [Abstract] [Full Text] [Related]

  • 6. Chimeric (mouse/human) anti-colon cancer antibody c30.6 inhibits the growth of human colorectal cancer xenografts in scid/scid mice.
    Mount PF, Sutton VR, Li W, Burgess J, McKEnzie IF, Pietersz GA, Trapani JA.
    Cancer Res; 1994 Dec 01; 54(23):6160-6. PubMed ID: 7954462
    [Abstract] [Full Text] [Related]

  • 7. Characterization of the colorectal carcinoma-associated antigen defined by monoclonal antibody D612.
    Fernsten PD, Primus FJ, Greiner JW, Simpson JF, Schlom J.
    Cancer Res; 1991 Feb 01; 51(3):926-34. PubMed ID: 1988133
    [Abstract] [Full Text] [Related]

  • 8. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
    Nakamura K, Koike M, Shitara K, Kuwana Y, Kiuragi K, Igarashi S, Hasegawa M, Hanai N.
    Cancer Res; 1994 Mar 15; 54(6):1511-6. PubMed ID: 8137257
    [Abstract] [Full Text] [Related]

  • 9. Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).
    Hutzell P, Kashmiri S, Colcher D, Primus FJ, Hand PH, Roselli M, Finch M, Yarranton G, Bodmer M, Whittle N.
    Cancer Res; 1991 Jan 01; 51(1):181-9. PubMed ID: 1988082
    [Abstract] [Full Text] [Related]

  • 10. A genetically engineered murine/human chimeric antibody retains specificity for human tumor-associated antigen.
    Sahagan BG, Dorai H, Saltzgaber-Muller J, Toneguzzo F, Guindon CA, Lilly SP, McDonald KW, Morrissey DV, Stone BA, Davis GL.
    J Immunol; 1986 Aug 01; 137(3):1066-74. PubMed ID: 3088107
    [Abstract] [Full Text] [Related]

  • 11. cDNA cloning and sequencing of a novel monoclonal antibody to carcinoembryonic antigen and construction of a mouse/human chimeric antibody.
    Shibaguchi H, Arakawa F, Imakiire T, Kuroki M, Kuroki M.
    Anticancer Res; 2003 Aug 01; 23(6a):4383-8. PubMed ID: 14666725
    [Abstract] [Full Text] [Related]

  • 12. Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.
    Xiang J, Moyana T, Kalra J, Hamilton T, Qi Y.
    Mol Biother; 1992 Dec 01; 4(4):174-83. PubMed ID: 1476671
    [Abstract] [Full Text] [Related]

  • 13. Characterization of a mouse/human chimeric monoclonal antibody (17-1A) to a colon cancer tumor-associated antigen.
    Shaw DR, Khazaeli MB, Sun LK, Ghrayeb J, Daddona PE, McKinney S, LoBuglio AF.
    J Immunol; 1987 Jun 15; 138(12):4534-8. PubMed ID: 3584980
    [Abstract] [Full Text] [Related]

  • 14. A monoclonal antibody (D612) with selective reactivity for malignant and normal gastro-intestinal epithelium.
    Muraro R, Nuti M, Natali PG, Bigotti A, Simpson JF, Primus FJ, Colcher D, Greiner JW, Schlom J.
    Int J Cancer; 1989 Apr 15; 43(4):598-607. PubMed ID: 2649441
    [Abstract] [Full Text] [Related]

  • 15. Lymphokine-activated killer cell cytotoxicity against human colon carcinomas enhanced by monoclonal antibody D612.
    Pendurthi TK, Parker R, Schlom J, Primus FJ.
    Int J Cancer; 1990 Dec 15; 46(6):1021-8. PubMed ID: 2123477
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies.
    Ortaldo JR, Woodhouse C, Morgan AC, Herberman RB, Cheresh DA, Reisfeld R.
    J Immunol; 1987 May 15; 138(10):3566-72. PubMed ID: 2437198
    [Abstract] [Full Text] [Related]

  • 18. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
    Christiaansen JE, Burnside SS, Sears DW.
    J Immunol; 1987 Apr 01; 138(7):2236-43. PubMed ID: 3549899
    [Abstract] [Full Text] [Related]

  • 19. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W, Nishioka Y, Ozaki S, Jalili A, Verma VK, Hanibuchi M, Abe S, Minakuchi K, Matsumoto T, Sone S.
    Lung Cancer; 2009 Jan 01; 63(1):23-31. PubMed ID: 18524412
    [Abstract] [Full Text] [Related]

  • 20. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
    Woodhouse CS, Morgan AC.
    Cancer Res; 1989 May 15; 49(10):2766-72. PubMed ID: 2713860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.